MANTRA is the new CORCYM post-market clinical follow-up study in a real-world setting LONDON–(BUSINESS WIRE)–CORCYM, the new, independent, medical device company dedicated to providing patients and cardiac surgeons with the best solutions to fight structural heart disease, announces today the enrollment of the first patient in the MANTRA study. MANTRA (Mitral, Aortic aNd Tricuspid post-maRket Study in a reAl-world […]